nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A5—Tacrolimus—atopic dermatitis	0.179	0.238	CbGbCtD
Argatroban—CYP3A4—Pimecrolimus—atopic dermatitis	0.117	0.156	CbGbCtD
Argatroban—CYP3A5—Hydrocortisone—atopic dermatitis	0.0728	0.0969	CbGbCtD
Argatroban—CYP3A4—Tacrolimus—atopic dermatitis	0.0698	0.0928	CbGbCtD
Argatroban—CYP3A4—Loratadine—atopic dermatitis	0.0511	0.0679	CbGbCtD
Argatroban—CYP3A4—Methylprednisolone—atopic dermatitis	0.0467	0.0621	CbGbCtD
Argatroban—CYP3A5—Dexamethasone—atopic dermatitis	0.0453	0.0602	CbGbCtD
Argatroban—CYP3A4—Triamcinolone—atopic dermatitis	0.0354	0.0471	CbGbCtD
Argatroban—CYP3A4—Betamethasone—atopic dermatitis	0.0304	0.0404	CbGbCtD
Argatroban—CYP3A4—Prednisolone—atopic dermatitis	0.03	0.0398	CbGbCtD
Argatroban—CYP3A4—Hydrocortisone—atopic dermatitis	0.0284	0.0378	CbGbCtD
Argatroban—CYP3A4—Prednisone—atopic dermatitis	0.0283	0.0376	CbGbCtD
Argatroban—CYP3A4—Dexamethasone—atopic dermatitis	0.0177	0.0235	CbGbCtD
Argatroban—F2—IL1 and megakaryotyces in obesity—FCER1A—atopic dermatitis	0.00478	0.12	CbGpPWpGaD
Argatroban—F2—IL1 and megakaryotyces in obesity—CCR3—atopic dermatitis	0.00233	0.0584	CbGpPWpGaD
Argatroban—F2—IL1 and megakaryotyces in obesity—TLR2—atopic dermatitis	0.00184	0.0462	CbGpPWpGaD
Argatroban—F2—IL1 and megakaryotyces in obesity—IL18—atopic dermatitis	0.00142	0.0355	CbGpPWpGaD
Argatroban—F2—Syndecan-4-mediated signaling events—CCL5—atopic dermatitis	0.00113	0.0282	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.000849	0.0212	CbGpPWpGaD
Argatroban—F2—IL1 and megakaryotyces in obesity—IFNG—atopic dermatitis	0.000831	0.0208	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—SELE—atopic dermatitis	0.000821	0.0206	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—CCL5—atopic dermatitis	0.000776	0.0194	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.000756	0.0189	CbGpPWpGaD
Argatroban—Dyspepsia—Loratadine—atopic dermatitis	0.000748	0.0036	CcSEcCtD
Argatroban—F2—IL1 and megakaryotyces in obesity—IL1B—atopic dermatitis	0.000741	0.0186	CbGpPWpGaD
Argatroban—Angiopathy—Tacrolimus—atopic dermatitis	0.000741	0.00356	CcSEcCtD
Argatroban—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.000734	0.00353	CcSEcCtD
Argatroban—Diarrhoea—Pimecrolimus—atopic dermatitis	0.00073	0.00351	CcSEcCtD
Argatroban—Dizziness—Dimenhydrinate—atopic dermatitis	0.00073	0.00351	CcSEcCtD
Argatroban—Dizziness—Diphenhydramine—atopic dermatitis	0.00073	0.00351	CcSEcCtD
Argatroban—Thrombophlebitis—Betamethasone—atopic dermatitis	0.000727	0.0035	CcSEcCtD
Argatroban—Thrombophlebitis—Dexamethasone—atopic dermatitis	0.000727	0.0035	CcSEcCtD
Argatroban—Constipation—Loratadine—atopic dermatitis	0.000727	0.00349	CcSEcCtD
Argatroban—Pain—Loratadine—atopic dermatitis	0.000727	0.00349	CcSEcCtD
Argatroban—Dermatitis bullous—Triamcinolone—atopic dermatitis	0.000726	0.00349	CcSEcCtD
Argatroban—Infection—Mometasone—atopic dermatitis	0.000725	0.00348	CcSEcCtD
Argatroban—Cardiac arrest—Prednisolone—atopic dermatitis	0.000717	0.00345	CcSEcCtD
Argatroban—Cardiac failure—Methylprednisolone—atopic dermatitis	0.000709	0.00341	CcSEcCtD
Argatroban—Vomiting—Diphenhydramine—atopic dermatitis	0.000702	0.00337	CcSEcCtD
Argatroban—Vomiting—Dimenhydrinate—atopic dermatitis	0.000702	0.00337	CcSEcCtD
Argatroban—Cardiac arrest—Hydrocortisone—atopic dermatitis	0.000701	0.00337	CcSEcCtD
Argatroban—Feeling abnormal—Loratadine—atopic dermatitis	0.0007	0.00337	CcSEcCtD
Argatroban—Rash—Diphenhydramine—atopic dermatitis	0.000696	0.00334	CcSEcCtD
Argatroban—Rash—Dimenhydrinate—atopic dermatitis	0.000696	0.00334	CcSEcCtD
Argatroban—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000695	0.00334	CcSEcCtD
Argatroban—Dermatitis—Diphenhydramine—atopic dermatitis	0.000695	0.00334	CcSEcCtD
Argatroban—Gastrointestinal pain—Loratadine—atopic dermatitis	0.000695	0.00334	CcSEcCtD
Argatroban—Headache—Dimenhydrinate—atopic dermatitis	0.000691	0.00332	CcSEcCtD
Argatroban—Headache—Diphenhydramine—atopic dermatitis	0.000691	0.00332	CcSEcCtD
Argatroban—Back pain—Tacrolimus—atopic dermatitis	0.000688	0.00331	CcSEcCtD
Argatroban—Vomiting—Pimecrolimus—atopic dermatitis	0.000678	0.00326	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.000678	0.017	CbGpPWpGaD
Argatroban—Rash—Pimecrolimus—atopic dermatitis	0.000673	0.00323	CcSEcCtD
Argatroban—Pulmonary oedema—Prednisone—atopic dermatitis	0.000672	0.00323	CcSEcCtD
Argatroban—Dermatitis—Pimecrolimus—atopic dermatitis	0.000672	0.00323	CcSEcCtD
Argatroban—Body temperature increased—Loratadine—atopic dermatitis	0.000672	0.00323	CcSEcCtD
Argatroban—Abdominal pain—Loratadine—atopic dermatitis	0.000672	0.00323	CcSEcCtD
Argatroban—Headache—Pimecrolimus—atopic dermatitis	0.000668	0.00321	CcSEcCtD
Argatroban—Cardiac arrest—Triamcinolone—atopic dermatitis	0.00066	0.00317	CcSEcCtD
Argatroban—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000659	0.00317	CcSEcCtD
Argatroban—Dermatitis bullous—Dexamethasone—atopic dermatitis	0.000659	0.00317	CcSEcCtD
Argatroban—Dermatitis bullous—Betamethasone—atopic dermatitis	0.000659	0.00317	CcSEcCtD
Argatroban—Cardiac arrest—Methylprednisolone—atopic dermatitis	0.000658	0.00316	CcSEcCtD
Argatroban—Nausea—Diphenhydramine—atopic dermatitis	0.000655	0.00315	CcSEcCtD
Argatroban—Nausea—Dimenhydrinate—atopic dermatitis	0.000655	0.00315	CcSEcCtD
Argatroban—Sepsis—Prednisone—atopic dermatitis	0.000655	0.00315	CcSEcCtD
Argatroban—Pain—Fluocinolone Acetonide—atopic dermatitis	0.000653	0.00314	CcSEcCtD
Argatroban—Dyspnoea—Mometasone—atopic dermatitis	0.00065	0.00313	CcSEcCtD
Argatroban—Cardiac failure—Dexamethasone—atopic dermatitis	0.000645	0.0031	CcSEcCtD
Argatroban—Cardiac failure—Betamethasone—atopic dermatitis	0.000645	0.0031	CcSEcCtD
Argatroban—Dyspepsia—Mometasone—atopic dermatitis	0.000642	0.00309	CcSEcCtD
Argatroban—Nausea—Pimecrolimus—atopic dermatitis	0.000634	0.00305	CcSEcCtD
Argatroban—Thrombophlebitis—Prednisone—atopic dermatitis	0.000633	0.00304	CcSEcCtD
Argatroban—Pain—Mometasone—atopic dermatitis	0.000624	0.003	CcSEcCtD
Argatroban—Cough—Tacrolimus—atopic dermatitis	0.000621	0.00298	CcSEcCtD
Argatroban—F2—Folate Metabolism—IL4—atopic dermatitis	0.000612	0.0153	CbGpPWpGaD
Argatroban—Chest pain—Tacrolimus—atopic dermatitis	0.000606	0.00291	CcSEcCtD
Argatroban—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000604	0.0029	CcSEcCtD
Argatroban—Cardiac arrest—Dexamethasone—atopic dermatitis	0.000599	0.00288	CcSEcCtD
Argatroban—Cardiac arrest—Betamethasone—atopic dermatitis	0.000599	0.00288	CcSEcCtD
Argatroban—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000596	0.00287	CcSEcCtD
Argatroban—Confusional state—Tacrolimus—atopic dermatitis	0.000585	0.00281	CcSEcCtD
Argatroban—Diarrhoea—Loratadine—atopic dermatitis	0.000581	0.0028	CcSEcCtD
Argatroban—Infection—Tacrolimus—atopic dermatitis	0.000577	0.00277	CcSEcCtD
Argatroban—Body temperature increased—Mometasone—atopic dermatitis	0.000577	0.00277	CcSEcCtD
Argatroban—Abdominal pain—Mometasone—atopic dermatitis	0.000577	0.00277	CcSEcCtD
Argatroban—Acute coronary syndrome—Prednisolone—atopic dermatitis	0.000573	0.00275	CcSEcCtD
Argatroban—Myocardial infarction—Prednisolone—atopic dermatitis	0.00057	0.00274	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.000569	0.0142	CbGpPWpGaD
Argatroban—Tachycardia—Tacrolimus—atopic dermatitis	0.000567	0.00272	CcSEcCtD
Argatroban—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000563	0.00271	CcSEcCtD
Argatroban—Dizziness—Loratadine—atopic dermatitis	0.000562	0.0027	CcSEcCtD
Argatroban—Cardiac failure—Prednisone—atopic dermatitis	0.000562	0.0027	CcSEcCtD
Argatroban—Acute coronary syndrome—Hydrocortisone—atopic dermatitis	0.00056	0.00269	CcSEcCtD
Argatroban—Myocardial infarction—Hydrocortisone—atopic dermatitis	0.000557	0.00268	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Prednisone—atopic dermatitis	0.000548	0.00264	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.000547	0.0137	CbGpPWpGaD
Argatroban—F2—Post-translational protein modification—GLB1—atopic dermatitis	0.000546	0.0137	CbGpPWpGaD
Argatroban—Hypotension—Tacrolimus—atopic dermatitis	0.000542	0.00261	CcSEcCtD
Argatroban—Vomiting—Loratadine—atopic dermatitis	0.00054	0.0026	CcSEcCtD
Argatroban—Rash—Loratadine—atopic dermatitis	0.000536	0.00258	CcSEcCtD
Argatroban—Dermatitis—Loratadine—atopic dermatitis	0.000535	0.00257	CcSEcCtD
Argatroban—Headache—Loratadine—atopic dermatitis	0.000532	0.00256	CcSEcCtD
Argatroban—Bradycardia—Prednisolone—atopic dermatitis	0.000531	0.00255	CcSEcCtD
Argatroban—Acute coronary syndrome—Triamcinolone—atopic dermatitis	0.000527	0.00253	CcSEcCtD
Argatroban—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	0.000526	0.00253	CcSEcCtD
Argatroban—Haemoglobin—Prednisolone—atopic dermatitis	0.000525	0.00252	CcSEcCtD
Argatroban—Myocardial infarction—Triamcinolone—atopic dermatitis	0.000524	0.00252	CcSEcCtD
Argatroban—Myocardial infarction—Methylprednisolone—atopic dermatitis	0.000523	0.00251	CcSEcCtD
Argatroban—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000523	0.00251	CcSEcCtD
Argatroban—Haemorrhage—Prednisolone—atopic dermatitis	0.000522	0.00251	CcSEcCtD
Argatroban—Cardiac arrest—Prednisone—atopic dermatitis	0.000521	0.00251	CcSEcCtD
Argatroban—Bradycardia—Hydrocortisone—atopic dermatitis	0.000519	0.00249	CcSEcCtD
Argatroban—Dyspnoea—Tacrolimus—atopic dermatitis	0.000518	0.00249	CcSEcCtD
Argatroban—Haemoglobin—Hydrocortisone—atopic dermatitis	0.000512	0.00246	CcSEcCtD
Argatroban—Dyspepsia—Tacrolimus—atopic dermatitis	0.000511	0.00246	CcSEcCtD
Argatroban—Haemorrhage—Hydrocortisone—atopic dermatitis	0.00051	0.00245	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000507	0.0127	CbGpPWpGaD
Argatroban—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000505	0.00243	CcSEcCtD
Argatroban—Nausea—Loratadine—atopic dermatitis	0.000505	0.00243	CcSEcCtD
Argatroban—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000501	0.00241	CcSEcCtD
Argatroban—Diarrhoea—Mometasone—atopic dermatitis	0.000499	0.0024	CcSEcCtD
Argatroban—Pain—Tacrolimus—atopic dermatitis	0.000496	0.00239	CcSEcCtD
Argatroban—Constipation—Tacrolimus—atopic dermatitis	0.000496	0.00239	CcSEcCtD
Argatroban—Bradycardia—Triamcinolone—atopic dermatitis	0.000489	0.00235	CcSEcCtD
Argatroban—Bradycardia—Methylprednisolone—atopic dermatitis	0.000487	0.00234	CcSEcCtD
Argatroban—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000486	0.00233	CcSEcCtD
Argatroban—Haemoglobin—Triamcinolone—atopic dermatitis	0.000482	0.00232	CcSEcCtD
Argatroban—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000482	0.00232	CcSEcCtD
Argatroban—Haemoglobin—Methylprednisolone—atopic dermatitis	0.000481	0.00231	CcSEcCtD
Argatroban—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000481	0.00231	CcSEcCtD
Argatroban—Haemorrhage—Triamcinolone—atopic dermatitis	0.00048	0.00231	CcSEcCtD
Argatroban—Haemorrhage—Methylprednisolone—atopic dermatitis	0.000479	0.0023	CcSEcCtD
Argatroban—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000478	0.0023	CcSEcCtD
Argatroban—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000478	0.0023	CcSEcCtD
Argatroban—Acute coronary syndrome—Dexamethasone—atopic dermatitis	0.000478	0.0023	CcSEcCtD
Argatroban—Acute coronary syndrome—Betamethasone—atopic dermatitis	0.000478	0.0023	CcSEcCtD
Argatroban—Myocardial infarction—Betamethasone—atopic dermatitis	0.000475	0.00229	CcSEcCtD
Argatroban—Myocardial infarction—Dexamethasone—atopic dermatitis	0.000475	0.00229	CcSEcCtD
Argatroban—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000475	0.00228	CcSEcCtD
Argatroban—Vomiting—Mometasone—atopic dermatitis	0.000464	0.00223	CcSEcCtD
Argatroban—Rash—Mometasone—atopic dermatitis	0.00046	0.00221	CcSEcCtD
Argatroban—Dermatitis—Mometasone—atopic dermatitis	0.000459	0.00221	CcSEcCtD
Argatroban—Body temperature increased—Tacrolimus—atopic dermatitis	0.000459	0.00221	CcSEcCtD
Argatroban—Abdominal pain—Tacrolimus—atopic dermatitis	0.000459	0.00221	CcSEcCtD
Argatroban—Headache—Mometasone—atopic dermatitis	0.000457	0.0022	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000455	0.0114	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—IFNG—atopic dermatitis	0.000455	0.0114	CbGpPWpGaD
Argatroban—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000454	0.00218	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.000446	0.0112	CbGpPWpGaD
Argatroban—Bradycardia—Betamethasone—atopic dermatitis	0.000443	0.00213	CcSEcCtD
Argatroban—Bradycardia—Dexamethasone—atopic dermatitis	0.000443	0.00213	CcSEcCtD
Argatroban—Haemoglobin—Betamethasone—atopic dermatitis	0.000438	0.0021	CcSEcCtD
Argatroban—Haemoglobin—Dexamethasone—atopic dermatitis	0.000438	0.0021	CcSEcCtD
Argatroban—Haemorrhage—Betamethasone—atopic dermatitis	0.000435	0.00209	CcSEcCtD
Argatroban—Haemorrhage—Dexamethasone—atopic dermatitis	0.000435	0.00209	CcSEcCtD
Argatroban—Angiopathy—Methylprednisolone—atopic dermatitis	0.000434	0.00209	CcSEcCtD
Argatroban—F2—GPCR ligand binding—CCL22—atopic dermatitis	0.000433	0.0108	CbGpPWpGaD
Argatroban—Nausea—Mometasone—atopic dermatitis	0.000433	0.00208	CcSEcCtD
Argatroban—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000428	0.00206	CcSEcCtD
Argatroban—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000416	0.002	CcSEcCtD
Argatroban—Myocardial infarction—Prednisone—atopic dermatitis	0.000414	0.00199	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—IL1B—atopic dermatitis	0.000406	0.0102	CbGpPWpGaD
Argatroban—Back pain—Triamcinolone—atopic dermatitis	0.000404	0.00194	CcSEcCtD
Argatroban—F2—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000402	0.0101	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—NPS—atopic dermatitis	0.000402	0.0101	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.000397	0.00995	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.000397	0.00995	CbGpPWpGaD
Argatroban—Diarrhoea—Tacrolimus—atopic dermatitis	0.000397	0.00191	CcSEcCtD
Argatroban—Angiopathy—Betamethasone—atopic dermatitis	0.000395	0.0019	CcSEcCtD
Argatroban—Angiopathy—Dexamethasone—atopic dermatitis	0.000395	0.0019	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.00039	0.00975	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CCL27—atopic dermatitis	0.000386	0.00967	CbGpPWpGaD
Argatroban—Bradycardia—Prednisone—atopic dermatitis	0.000386	0.00186	CcSEcCtD
Argatroban—Dizziness—Tacrolimus—atopic dermatitis	0.000384	0.00185	CcSEcCtD
Argatroban—Haemoglobin—Prednisone—atopic dermatitis	0.000381	0.00183	CcSEcCtD
Argatroban—Haemorrhage—Prednisone—atopic dermatitis	0.000379	0.00182	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK8—atopic dermatitis	0.000378	0.00946	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IFNG—atopic dermatitis	0.00037	0.00926	CbGpPWpGaD
Argatroban—Vomiting—Tacrolimus—atopic dermatitis	0.000369	0.00177	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000367	0.00918	CbGpPWpGaD
Argatroban—Rash—Tacrolimus—atopic dermatitis	0.000366	0.00176	CcSEcCtD
Argatroban—Dermatitis—Tacrolimus—atopic dermatitis	0.000366	0.00176	CcSEcCtD
Argatroban—Cough—Triamcinolone—atopic dermatitis	0.000365	0.00175	CcSEcCtD
Argatroban—Headache—Tacrolimus—atopic dermatitis	0.000364	0.00175	CcSEcCtD
Argatroban—Tachycardia—Prednisolone—atopic dermatitis	0.000362	0.00174	CcSEcCtD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.00036	0.00901	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.00036	0.00901	CbGpPWpGaD
Argatroban—Infection—Hydrocortisone—atopic dermatitis	0.00036	0.00173	CcSEcCtD
Argatroban—Tachycardia—Hydrocortisone—atopic dermatitis	0.000353	0.0017	CcSEcCtD
Argatroban—F2—GPCR ligand binding—CCL17—atopic dermatitis	0.000347	0.00867	CbGpPWpGaD
Argatroban—Nausea—Tacrolimus—atopic dermatitis	0.000345	0.00166	CcSEcCtD
Argatroban—Angiopathy—Prednisone—atopic dermatitis	0.000344	0.00165	CcSEcCtD
Argatroban—Confusional state—Methylprednisolone—atopic dermatitis	0.000343	0.00165	CcSEcCtD
Argatroban—Infection—Triamcinolone—atopic dermatitis	0.000339	0.00163	CcSEcCtD
Argatroban—Hypotension—Hydrocortisone—atopic dermatitis	0.000338	0.00163	CcSEcCtD
Argatroban—Infection—Methylprednisolone—atopic dermatitis	0.000338	0.00162	CcSEcCtD
Argatroban—Tachycardia—Triamcinolone—atopic dermatitis	0.000333	0.0016	CcSEcCtD
Argatroban—Tachycardia—Methylprednisolone—atopic dermatitis	0.000332	0.0016	CcSEcCtD
Argatroban—F2—Folate Metabolism—IL1B—atopic dermatitis	0.00033	0.00826	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IL2—atopic dermatitis	0.000329	0.00823	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	0.000327	0.00819	CbGpPWpGaD
Argatroban—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000319	0.00153	CcSEcCtD
Argatroban—Hypotension—Methylprednisolone—atopic dermatitis	0.000318	0.00153	CcSEcCtD
Argatroban—Pain—Prednisolone—atopic dermatitis	0.000317	0.00152	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000315	0.00788	CbGpPWpGaD
Argatroban—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000313	0.0015	CcSEcCtD
Argatroban—Pain—Hydrocortisone—atopic dermatitis	0.00031	0.00149	CcSEcCtD
Argatroban—Infection—Betamethasone—atopic dermatitis	0.000307	0.00148	CcSEcCtD
Argatroban—Infection—Dexamethasone—atopic dermatitis	0.000307	0.00148	CcSEcCtD
Argatroban—Feeling abnormal—Prednisolone—atopic dermatitis	0.000306	0.00147	CcSEcCtD
Argatroban—Dyspnoea—Triamcinolone—atopic dermatitis	0.000304	0.00146	CcSEcCtD
Argatroban—Tachycardia—Dexamethasone—atopic dermatitis	0.000302	0.00145	CcSEcCtD
Argatroban—Tachycardia—Betamethasone—atopic dermatitis	0.000302	0.00145	CcSEcCtD
Argatroban—Dyspepsia—Triamcinolone—atopic dermatitis	0.0003	0.00144	CcSEcCtD
Argatroban—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000299	0.00144	CcSEcCtD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—atopic dermatitis	0.000299	0.00749	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000299	0.00748	CbGpPWpGaD
Argatroban—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000298	0.00143	CcSEcCtD
Argatroban—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000296	0.00142	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—TNF—atopic dermatitis	0.000294	0.00737	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000294	0.00736	CbGpPWpGaD
Argatroban—Pain—Triamcinolone—atopic dermatitis	0.000292	0.0014	CcSEcCtD
Argatroban—Hypotension—Betamethasone—atopic dermatitis	0.000289	0.00139	CcSEcCtD
Argatroban—Hypotension—Dexamethasone—atopic dermatitis	0.000289	0.00139	CcSEcCtD
Argatroban—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000286	0.00138	CcSEcCtD
Argatroban—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000286	0.00138	CcSEcCtD
Argatroban—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000281	0.00135	CcSEcCtD
Argatroban—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.00028	0.00135	CcSEcCtD
Argatroban—F2—GPCR ligand binding—CCL11—atopic dermatitis	0.000279	0.00699	CbGpPWpGaD
Argatroban—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000278	0.00134	CcSEcCtD
Argatroban—F2—Hemostasis—KIF3A—atopic dermatitis	0.000276	0.00691	CbGpPWpGaD
Argatroban—Hypersensitivity—Prednisolone—atopic dermatitis	0.000273	0.00131	CcSEcCtD
Argatroban—Dyspepsia—Betamethasone—atopic dermatitis	0.000272	0.00131	CcSEcCtD
Argatroban—Dyspepsia—Dexamethasone—atopic dermatitis	0.000272	0.00131	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000271	0.00679	CbGpPWpGaD
Argatroban—Body temperature increased—Triamcinolone—atopic dermatitis	0.00027	0.0013	CcSEcCtD
Argatroban—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000269	0.00129	CcSEcCtD
Argatroban—Infection—Prednisone—atopic dermatitis	0.000268	0.00129	CcSEcCtD
Argatroban—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000267	0.00128	CcSEcCtD
Argatroban—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000267	0.00128	CcSEcCtD
Argatroban—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000267	0.00128	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000267	0.00667	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000267	0.00667	CbGpPWpGaD
Argatroban—Pain—Betamethasone—atopic dermatitis	0.000265	0.00127	CcSEcCtD
Argatroban—Pain—Dexamethasone—atopic dermatitis	0.000265	0.00127	CcSEcCtD
Argatroban—Tachycardia—Prednisone—atopic dermatitis	0.000263	0.00126	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000262	0.00656	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000261	0.00654	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—GLB1—atopic dermatitis	0.000259	0.00649	CbGpPWpGaD
Argatroban—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000255	0.00123	CcSEcCtD
Argatroban—Feeling abnormal—Betamethasone—atopic dermatitis	0.000255	0.00123	CcSEcCtD
Argatroban—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000253	0.00122	CcSEcCtD
Argatroban—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000253	0.00122	CcSEcCtD
Argatroban—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000251	0.00121	CcSEcCtD
Argatroban—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000251	0.0012	CcSEcCtD
Argatroban—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000248	0.00119	CcSEcCtD
Argatroban—Dizziness—Prednisolone—atopic dermatitis	0.000245	0.00118	CcSEcCtD
Argatroban—Body temperature increased—Dexamethasone—atopic dermatitis	0.000245	0.00118	CcSEcCtD
Argatroban—Abdominal pain—Dexamethasone—atopic dermatitis	0.000245	0.00118	CcSEcCtD
Argatroban—Abdominal pain—Betamethasone—atopic dermatitis	0.000245	0.00118	CcSEcCtD
Argatroban—Body temperature increased—Betamethasone—atopic dermatitis	0.000245	0.00118	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000244	0.00611	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TNF—atopic dermatitis	0.00024	0.00599	CbGpPWpGaD
Argatroban—Dizziness—Hydrocortisone—atopic dermatitis	0.000239	0.00115	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—IL6—atopic dermatitis	0.000238	0.00595	CbGpPWpGaD
Argatroban—Dyspepsia—Prednisone—atopic dermatitis	0.000237	0.00114	CcSEcCtD
Argatroban—Rash—Prednisolone—atopic dermatitis	0.000234	0.00112	CcSEcCtD
Argatroban—Dermatitis—Prednisolone—atopic dermatitis	0.000234	0.00112	CcSEcCtD
Argatroban—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000233	0.00112	CcSEcCtD
Argatroban—Headache—Prednisolone—atopic dermatitis	0.000232	0.00112	CcSEcCtD
Argatroban—Constipation—Prednisone—atopic dermatitis	0.00023	0.00111	CcSEcCtD
Argatroban—Vomiting—Hydrocortisone—atopic dermatitis	0.00023	0.00111	CcSEcCtD
Argatroban—Rash—Hydrocortisone—atopic dermatitis	0.000228	0.0011	CcSEcCtD
Argatroban—Dermatitis—Hydrocortisone—atopic dermatitis	0.000228	0.0011	CcSEcCtD
Argatroban—F2—GPCR ligand binding—CCR3—atopic dermatitis	0.000228	0.0057	CbGpPWpGaD
Argatroban—Headache—Hydrocortisone—atopic dermatitis	0.000227	0.00109	CcSEcCtD
Argatroban—Dizziness—Triamcinolone—atopic dermatitis	0.000225	0.00108	CcSEcCtD
Argatroban—Dizziness—Methylprednisolone—atopic dermatitis	0.000225	0.00108	CcSEcCtD
Argatroban—F2—Hemostasis—SELE—atopic dermatitis	0.000223	0.00557	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCL22—atopic dermatitis	0.000222	0.00557	CbGpPWpGaD
Argatroban—Feeling abnormal—Prednisone—atopic dermatitis	0.000222	0.00107	CcSEcCtD
Argatroban—Gastrointestinal pain—Prednisone—atopic dermatitis	0.00022	0.00106	CcSEcCtD
Argatroban—Nausea—Prednisolone—atopic dermatitis	0.00022	0.00106	CcSEcCtD
Argatroban—F2—GPCR downstream signaling—CCL27—atopic dermatitis	0.000218	0.00546	CbGpPWpGaD
Argatroban—Vomiting—Triamcinolone—atopic dermatitis	0.000217	0.00104	CcSEcCtD
Argatroban—Vomiting—Methylprednisolone—atopic dermatitis	0.000216	0.00104	CcSEcCtD
Argatroban—Nausea—Hydrocortisone—atopic dermatitis	0.000215	0.00103	CcSEcCtD
Argatroban—Rash—Triamcinolone—atopic dermatitis	0.000215	0.00103	CcSEcCtD
Argatroban—Dermatitis—Triamcinolone—atopic dermatitis	0.000215	0.00103	CcSEcCtD
Argatroban—Rash—Methylprednisolone—atopic dermatitis	0.000215	0.00103	CcSEcCtD
Argatroban—Dermatitis—Methylprednisolone—atopic dermatitis	0.000214	0.00103	CcSEcCtD
Argatroban—Headache—Triamcinolone—atopic dermatitis	0.000214	0.00103	CcSEcCtD
Argatroban—Headache—Methylprednisolone—atopic dermatitis	0.000213	0.00102	CcSEcCtD
Argatroban—Abdominal pain—Prednisone—atopic dermatitis	0.000213	0.00102	CcSEcCtD
Argatroban—Body temperature increased—Prednisone—atopic dermatitis	0.000213	0.00102	CcSEcCtD
Argatroban—Diarrhoea—Betamethasone—atopic dermatitis	0.000212	0.00102	CcSEcCtD
Argatroban—Diarrhoea—Dexamethasone—atopic dermatitis	0.000212	0.00102	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000211	0.00529	CbGpPWpGaD
Argatroban—Dizziness—Betamethasone—atopic dermatitis	0.000205	0.000983	CcSEcCtD
Argatroban—Dizziness—Dexamethasone—atopic dermatitis	0.000205	0.000983	CcSEcCtD
Argatroban—F2—GPCR ligand binding—TAC1—atopic dermatitis	0.000203	0.00508	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—NPS—atopic dermatitis	0.000203	0.00508	CbGpPWpGaD
Argatroban—Nausea—Triamcinolone—atopic dermatitis	0.000203	0.000974	CcSEcCtD
Argatroban—Nausea—Methylprednisolone—atopic dermatitis	0.000202	0.000971	CcSEcCtD
Argatroban—F2—GPCR ligand binding—CXCR3—atopic dermatitis	0.000199	0.00498	CbGpPWpGaD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000199	0.00497	CbGpPWpGaD
Argatroban—Hypersensitivity—Prednisone—atopic dermatitis	0.000199	0.000954	CcSEcCtD
Argatroban—F2—Signaling by GPCR—CCL27—atopic dermatitis	0.000198	0.00496	CbGpPWpGaD
Argatroban—Vomiting—Dexamethasone—atopic dermatitis	0.000197	0.000946	CcSEcCtD
Argatroban—Vomiting—Betamethasone—atopic dermatitis	0.000197	0.000946	CcSEcCtD
Argatroban—F2—Metabolism of proteins—CMA1—atopic dermatitis	0.000196	0.00492	CbGpPWpGaD
Argatroban—Rash—Dexamethasone—atopic dermatitis	0.000195	0.000938	CcSEcCtD
Argatroban—Rash—Betamethasone—atopic dermatitis	0.000195	0.000938	CcSEcCtD
Argatroban—Dermatitis—Betamethasone—atopic dermatitis	0.000195	0.000937	CcSEcCtD
Argatroban—Dermatitis—Dexamethasone—atopic dermatitis	0.000195	0.000937	CcSEcCtD
Argatroban—Headache—Betamethasone—atopic dermatitis	0.000194	0.000932	CcSEcCtD
Argatroban—Headache—Dexamethasone—atopic dermatitis	0.000194	0.000932	CcSEcCtD
Argatroban—F2—Folate Metabolism—IL6—atopic dermatitis	0.000193	0.00484	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—TNF—atopic dermatitis	0.00019	0.00476	CbGpPWpGaD
Argatroban—Diarrhoea—Prednisone—atopic dermatitis	0.000184	0.000886	CcSEcCtD
Argatroban—Nausea—Betamethasone—atopic dermatitis	0.000184	0.000883	CcSEcCtD
Argatroban—Nausea—Dexamethasone—atopic dermatitis	0.000184	0.000883	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000182	0.00455	CbGpPWpGaD
Argatroban—Dizziness—Prednisone—atopic dermatitis	0.000178	0.000856	CcSEcCtD
Argatroban—F2—Signaling by GPCR—CCL17—atopic dermatitis	0.000178	0.00445	CbGpPWpGaD
Argatroban—Vomiting—Prednisone—atopic dermatitis	0.000171	0.000824	CcSEcCtD
Argatroban—Rash—Prednisone—atopic dermatitis	0.00017	0.000817	CcSEcCtD
Argatroban—Dermatitis—Prednisone—atopic dermatitis	0.00017	0.000816	CcSEcCtD
Argatroban—Headache—Prednisone—atopic dermatitis	0.000169	0.000811	CcSEcCtD
Argatroban—F2—Hemostasis—IL5—atopic dermatitis	0.000169	0.00422	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000164	0.0041	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CXCL10—atopic dermatitis	0.000161	0.00403	CbGpPWpGaD
Argatroban—Nausea—Prednisone—atopic dermatitis	0.00016	0.000769	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—IL6—atopic dermatitis	0.000154	0.00384	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000148	0.0037	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCL11—atopic dermatitis	0.000143	0.00359	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FCER2—atopic dermatitis	0.000141	0.00354	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CCL5—atopic dermatitis	0.000138	0.00347	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL22—atopic dermatitis	0.000131	0.00329	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCR3—atopic dermatitis	0.000129	0.00322	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	0.000125	0.00313	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CCR5—atopic dermatitis	0.000125	0.00312	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL27—atopic dermatitis	0.000117	0.00293	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCR3—atopic dermatitis	0.000117	0.00292	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—TAC1—atopic dermatitis	0.000115	0.00287	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—NPS—atopic dermatitis	0.000115	0.00287	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000112	0.00282	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—IL5—atopic dermatitis	0.000107	0.00267	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL17—atopic dermatitis	0.000105	0.00263	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—TAC1—atopic dermatitis	0.000104	0.00261	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—NPS—atopic dermatitis	0.000104	0.00261	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCR3—atopic dermatitis	0.000102	0.00256	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	9.9e-05	0.00248	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL5—atopic dermatitis	9.68e-05	0.00242	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KIF3A—atopic dermatitis	9.36e-05	0.00234	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCL10—atopic dermatitis	9.09e-05	0.00228	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL11—atopic dermatitis	8.47e-05	0.00212	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CMA1—atopic dermatitis	8.47e-05	0.00212	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCL10—atopic dermatitis	8.26e-05	0.00207	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT6—atopic dermatitis	7.96e-05	0.00199	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCL5—atopic dermatitis	7.83e-05	0.00196	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CXCL8—atopic dermatitis	7.54e-05	0.00189	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	7.51e-05	0.00188	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCL5—atopic dermatitis	7.11e-05	0.00178	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCR5—atopic dermatitis	7.05e-05	0.00176	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCR3—atopic dermatitis	6.9e-05	0.00173	CbGpPWpGaD
Argatroban—F2—Hemostasis—IL2—atopic dermatitis	6.45e-05	0.00161	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCR5—atopic dermatitis	6.4e-05	0.0016	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GLB1—atopic dermatitis	6.16e-05	0.00154	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NPS—atopic dermatitis	6.15e-05	0.00154	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TAC1—atopic dermatitis	6.15e-05	0.00154	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCR3—atopic dermatitis	6.03e-05	0.00151	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ADSL—atopic dermatitis	5.9e-05	0.00148	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL5—atopic dermatitis	5.72e-05	0.00143	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CXCL8—atopic dermatitis	5.31e-05	0.00133	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCL10—atopic dermatitis	4.88e-05	0.00122	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCL8—atopic dermatitis	4.26e-05	0.00107	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL5—atopic dermatitis	4.2e-05	0.00105	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—IL2—atopic dermatitis	4.07e-05	0.00102	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NGF—atopic dermatitis	3.89e-05	0.000973	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCL8—atopic dermatitis	3.87e-05	0.000969	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCR5—atopic dermatitis	3.78e-05	0.000947	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL2—atopic dermatitis	3.7e-05	0.000926	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NFKBIA—atopic dermatitis	3.21e-05	0.000803	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GLB1—atopic dermatitis	2.86e-05	0.000716	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ADSL—atopic dermatitis	2.74e-05	0.000687	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCL8—atopic dermatitis	2.29e-05	0.000572	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL2—atopic dermatitis	2.19e-05	0.000547	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6—atopic dermatitis	2.17e-05	0.000544	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK8—atopic dermatitis	2.01e-05	0.000503	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPARA—atopic dermatitis	2e-05	0.0005	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6—atopic dermatitis	1.28e-05	0.000322	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPARA—atopic dermatitis	9.29e-06	0.000232	CbGpPWpGaD
